Pictet Asset Management Holding Sa Iovance Biotherapeutics, Inc. Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 27,122 shares of IOVA stock, worth $60,753. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,122
Previous 920,461
97.05%
Holding current value
$60,753
Previous $3.07 Million
98.5%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IOVA
# of Institutions
293Shares Held
233MCall Options Held
1.14MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$64.9 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$56.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$47.5 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$26.5 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.2 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $353M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...